Syndax Pharmaceuticals, Inc. (SNDX)
23.68
-0.09
(-0.38%)
USD |
NASDAQ |
Mar 18, 15:59
23.67
-0.01
(-0.04%)
After-Hours: 20:00
Syndax Pharmaceuticals EPS Diluted (Quarterly) : -0.7786 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Cogent Biosciences, Inc. | -0.6934 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -68.01M |
| Revenue (Quarterly) | 68.73M |
| Total Expenses (Quarterly) | 136.74M |
| Enterprise Value | 2.048B |
| Gross Profit Margin (Quarterly) | 96.06% |
| Profit Margin (Quarterly) | -98.96% |
| Earnings Yield | -13.92% |
| Normalized Earnings Yield | -13.92 |